One of the biggest challenges for a young MedTech start-up is to effectively navigate the regulatory landscape. Over these years, DxD Hub has been an indispensable partner, providing us with both regulatory and product support in realizing our product's vision. It has been a truly fulfilling experience working with the team.
Mr Michael Cheng
TIIM Healthcare, COO


The highly anticipated release of our first clinical trial coincided with the opening of our new headquarters in Singapore, where we are now partnering with DxD Hub, one of the most influential research and development centers in the world.
Dr Sebastian Bhakdi
X-Zell, Founder and CEO


Our partnership with DxD Hub was forged during Singapore's initial response to COVID-19. At the time, global supply chains had broken down. We signed the collaboration in 1 week, and built our test-kit manufacturing facilities in 6 weeks, with DxD support. DxD is able to work at the speed of business and is a strategic partner for Advanced MedTech.
Mr Abel Ang
Advanced MedTech, CEO


Parkway Laboratories has been in close partnership with DxD Hub since the beginning of the COVID-19 pandemic as early adopters of new diagnostic platforms that gave our frontline clinicians the necessary detection tools to make astute clinical decisions. We are now delighted to continue this partnership, and look forward to other innovative solutions from DxD Hub.
Dr Daniel Tan
Parkway Laboratories, CEO


Respiree is absolutely delighted to have partnered with DxD Hub and team in the development of digital health platform technologies for the broad cardio-pulmonary disease space. We are excited at the possibilities ahead and look forward to further leverage on the clinical productization and in-depth expertise of DxD Hub as we add-value to our present systems for the betterment of healthcare.
Dr Gurpreet Singh
Respiree, Founder


Through this initiative, we are partnering with DxD Hub because they have the connections with industry partners, the big and small companies in the ASEAN region, and they will actually match our technologies, our scientists to the right channels and maybe also guide us to the valleys of death.
Dr Jaime Montoya
ASEAN-NDI, Chairman

